Press & Media hub

Press contact

Jennifer Plankenbühler

Press & Medical PR Lead
Headquarters
Sanity Group GmbH
Jägerstrasse 28-31
10117 Berlin, Germany
Follow

Download media assets

Sanity Group's press images high and web resolution folder includes: Office & Labs, Founders, Management Team, Sanity Group Staff, Endosane Pharmaceuticals Staff, Belfry Medical Staff, Sanity Group Brands (product images & logos).
Sanity Group digital press release PDF includes: About the company, factsheet, quotes and portraits (only available in German).
Short biographies & careers of Sanity Group founders Finn Hänsel and Fabian Friede (available in German and English).

Latest news

March 9, 2026
Sanity Group
Das neue Cannabisgesetz (CanG): Was bedeutet es für Patient:innen? 
February 17, 2026
Sanity Group
Hola
February 17, 2026
Sanity Group
Hello world!
February 12, 2026
Sanity Group
Hello world!

In the media

March 12, 2026
Sanity Group
Big Tobacco Jumps Into Germany’s Pot Industry alongside Snoop Dogg
March 12, 2026
Sanity Group
Big Tobacco Jumps Into Germany’s Pot Industry alongside Snoop Dogg
March 12, 2026
Sanity Group
Big Tobacco Jumps Into Germany’s Pot Industry alongside Snoop Dogg

Interested in covering Sanity Group?

About Sanity Group

At Sanity Group, we pursue a clear goal: Unlock the full health potential of cannabinoids

The Sanity Group was founded in Berlin in 2018 by Finn Hänsel (Founder & CEO) and Fabian Friede (Founder & Addvisor).

The Berlin-based health and life science company aims to improve people’s quality of life through the use of cannabinoids and the utilization of the endocannabinoid system. The focus is on medical products and pharmaceuticals (medical cannabis; finished pharmaceuticals) and cannabinoid-based consumer goods.

Our Investors

Our Business Angles

“It’s important to understand the full potential of the plant – that’s what we’re working for, to bring cannabis back to the center of European society.”
Finn Hänsel
Senior Scientific Affairs Manager

Our brands

An overview of our brands related to medical cannabis, scientific pilot projects on recreational cannabis and CBD products.
ZOIKS - the latest brand from the Sanity Group - aims to improve patient care with high-quality medicinal cannabis through particularly affordable medicines.
avaay Medical supplies patients through pharmacies with high-quality cannabis medicines - for a personalised therapy with natural products.
Vayamed is a fully licensed pharmaceutical company that distributes medical cannabis medicines to pharmacies and clinical facilities - focusing on the supply to patients with statutory health insurance.
Grashaus Projects is an official pilot project for recreational cannabis in Switzerland, investigating the effects of the legal sale of THC-containing products on the consumption behaviour of study participants.
vaay positions itself as a "wellbeing brand" of the Sanity Group, focusing on CBD products in the fields of cosmetics, dietary supplements, and lifestyle.

Subscribe Sanity Group press releases

We are happy to provide journalists, bloggers and media representatives with relevant information about Sanity Group on a regular basis. Subscribe to receive our press releases directly in the future.

We would also be pleased if you keep us informed about publications and send us a specimen copy (gladly as a PDF) to presse@sanitygroup.com.

Thank you very much!
PR Subscription Form

I agree to Sanity Group GmbH sending me press releases and news from the company that are relevant to the press. I can unsubscribe from the distribution list at any time. Sanity Group GmbH guarantees that the data will not be passed on to third parties and that it will only contact me for press information purposes.

Get in touch

For general enquiries, please email info@sanitygroup.com. For specific topics you can reach the right team in the sidebar. You’ll also find links for cultivation collaborations and pilot studies in our footer.

Interested in a career at Sanity Group?

Visit careers page